Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

High-performance liquid chromatography assay for moxifloxacin in brain tissue and plasma: validation in a pharmacokinetic study in a murine model of cerebral listeriosis.

Respaud R, Grayo S, Singlas E, Dubouch S, Le Monnier A, Lott MC.

J Anal Methods Chem. 2012;2012:436349. doi: 10.1155/2012/436349. Epub 2012 Mar 14.

2.

[Position statements regarding usage of biosimilars of Epoetins. Position paper of the Société de néphrologie, Société francophone de dialyse, and Société de néphrologie pédiatrique].

Bouchet JL, Brunet P, Canaud B, Chanliau J, Combe C, Deray G, Houillier P, Kourilsky O, Ledneva E, Niaudet P, Ortiz JP, Pavlovic M, Ryckelynck JP, Singlas E, Verhelst D; Société de néphrologie, Société francophone de dialyse, Société de néphrologie pédiatrique; Société francophone de dialyse; Société de néphrologie pédiatrique.

Nephrol Ther. 2009 Feb;5(1):61-6. doi: 10.1016/j.nephro.2008.10.006. Epub 2008 Dec 11. French.

PMID:
19084489
3.

Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosis.

Grayo S, Lott-Desroches MC, Dussurget O, Respaud R, Fontanet A, Join-Lambert O, Singlas E, Le Monnier A.

Antimicrob Agents Chemother. 2008 Sep;52(9):3210-5. doi: 10.1128/AAC.00177-08. Epub 2008 Jun 23.

4.

Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.

Gimenez F, Foeillet E, Bourdon O, Weller S, Garret C, Bidault R, Singlas E.

Clin Pharmacokinet. 2004;43(10):685-92.

PMID:
15244498
5.

Glucocorticoid pharmacokinetics and growth retardation in children with renal transplants.

Chavatte C, Guest G, Proust V, Le Bihan C, Gimenez F, Maisin A, Loirat C, Mogenet A, Bresson JL, Hankard R, Broyer M, Niaudet P, Singlas E.

Pediatr Nephrol. 2004 Aug;19(8):898-904. Epub 2004 Jun 3.

PMID:
15197639
6.

Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice.

Barraud de Lagerie S, Comets E, Gautrand C, Fernandez C, Auchere D, Singlas E, Mentre F, Gimenez F.

Br J Pharmacol. 2004 Apr;141(7):1214-22. Epub 2004 Mar 15.

7.

Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans.

Imbert F, Jardin M, Fernandez C, Gantier JC, Dromer F, Baron G, Mentre F, Van Beijsterveldt L, Singlas E, Gimenez F.

Drug Metab Dispos. 2003 Mar;31(3):319-25.

PMID:
12584159
8.

Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography.

Correas JM, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC.

Ultrasound Med Biol. 2001 Apr;27(4):565-70.

PMID:
11368867
9.

Sputum itraconazole concentrations in cystic fibrosis patients.

Sermet-Gaudelus I, Lesne-Hulin A, Lenoir G, Singlas E, Berche P, Hennequin C.

Antimicrob Agents Chemother. 2001 Jun;45(6):1937-8.

10.
11.

[Traceability of drugs derived from blood: regulation and pharmaco-economic implications after 24 months of application in Paris CHU].

Lesne-Hulin A, Bourget P, Silvie M, Barath V, Singlas E.

Pathol Biol (Paris). 1997 Nov;45(9):741-50. French.

PMID:
9538473
12.

Drug interactions with antiviral drugs.

Taburet AM, Singlas E.

Clin Pharmacokinet. 1996 May;30(5):385-401. Review.

PMID:
8743337
13.

Cimetidine does not alter sparfloxacin pharmacokinetics.

Gries JM, Honorato J, Taburet AM, Alvarez MP, Sadaba B, Azanza JR, Singlas E.

Int J Clin Pharmacol Ther. 1995 Nov;33(11):585-7.

PMID:
8688981
14.

[Clinical pharmacokinetics of azithromycin].

Singlas E.

Pathol Biol (Paris). 1995 Jun;43(6):505-11. Review. French.

PMID:
8539072
15.

Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers.

Taburet AM, Singlas E, Glass RC, Thomas F, Leutenegger E.

J Clin Pharm Ther. 1995 Apr;20(2):101-7.

PMID:
7650070
16.

Pharmacokinetics of a low molecular weight heparin (reviparine) in hemodialyzed patients.

Baumelou A, Singlas E, Petitclerc T, Desmichels D, Jacobs C, Soria J.

Nephron. 1994;68(2):202-6.

PMID:
7830857
17.

Penetration of foscarnet into cerebrospinal fluid of AIDS patients.

Raffi F, Taburet AM, Ghaleh B, Huart A, Singlas E.

Antimicrob Agents Chemother. 1993 Sep;37(9):1777-80.

18.

Randomized study of two doses of didanosine in children infected with human immunodeficiency virus.

Blanche S, Calvez T, Rouzioux C, Ortigao MB, Taburet AM, Ferroni A, Debre M, Wintrebert F, Singlas E, Costagliola D, et al.

J Pediatr. 1993 Jun;122(6):966-73.

PMID:
8501579
19.

Absorption of zidovudine in patients with diarrhoea.

Zorza G, Beaugerie L, Taburet AM, Le Quintrec Y, Singlas E.

Eur J Clin Pharmacol. 1993;44(5):501-3.

PMID:
8359192
20.

Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis.

Fillastre JP, Taburet AM, Fialaire A, Etienne I, Bidault R, Singlas E.

Drugs Exp Clin Res. 1993;19(1):25-32.

PMID:
8223137
21.

[Diffusion of cefpirome in ascitic fluid].

Taugourdeau MC, Laurent-Puig P, Hagège H, Taburet AM, Etienne JP, Singlas E.

Gastroenterol Clin Biol. 1993;17(11):878-9. French. No abstract available.

PMID:
8143964
22.

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.

Taburet AM, Katlama C, Blanshard C, Zorza G, Gazzard D, Dohin E, Gazzard BG, Frostegard C, Singlas E.

Antimicrob Agents Chemother. 1992 Sep;36(9):1821-4.

23.

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

Singlas E, Taburet AM, Borsa Lebas F, Parent de Curzon O, Sobel A, Chauveau P, Viron B, al Khayat R, Poignet JL, Mignon F, et al.

Antimicrob Agents Chemother. 1992 Jul;36(7):1519-24.

24.

Theophylline steady state pharmacokinetics is not altered by omeprazole.

Taburet AM, Geneve J, Bocquentin M, Simoneau G, Caulin C, Singlas E.

Eur J Clin Pharmacol. 1992;42(3):343-5.

PMID:
1577056
25.

Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound.

Pons JC, Taburet AM, Singlas E, Delfraissy JF, Papiernik E.

Eur J Obstet Gynecol Reprod Biol. 1991 Jul 25;40(3):229-31.

PMID:
1879598
26.

Pharmacokinetics of newer drugs in patients with renal impairment (Part II).

Singlas E, Fillastre JP.

Clin Pharmacokinet. 1991 May;20(5):389-410. Review.

PMID:
1879096
27.

Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

Fillastre JP, Singlas E.

Clin Pharmacokinet. 1991 Apr;20(4):293-310. Review.

PMID:
2036748
28.

Fetoplacental passage of 2',3'-dideoxyinosine.

Pons JC, Boubon MC, Taburet AM, Singlas E, Chambrin V, Frydman R, Papiernik E, Delfraissy JF.

Lancet. 1991 Mar 23;337(8743):732. No abstract available.

PMID:
1672193
29.

Pharmacokinetics of metoclopramide in patients with liver cirrhosis.

Magueur E, Hagege H, Attali P, Singlas E, Etienne JP, Taburet AM.

Br J Clin Pharmacol. 1991 Feb;31(2):185-7.

30.

Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.

Taburet AM, Devillers A, Thomare P, Fillastre JP, Veyssier P, Singlas E.

Clin Pharmacokinet. 1990 Jul;19(1):80-8.

PMID:
2116257
31.

Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.

Singlas E, Leroy A, Sultan E, Godin M, Moulin B, Taburet AM, Dhib M, Fillastre JP.

Clin Pharmacokinet. 1990 Jul;19(1):67-79.

PMID:
2116256
32.

Pharmacokinetics of zidovudine in patients with liver cirrhosis.

Taburet AM, Naveau S, Zorza G, Colin JN, Delfraissy JF, Chaput JC, Singlas E.

Clin Pharmacol Ther. 1990 Jun;47(6):731-9.

PMID:
2357867
33.

[Clinical pharmacokinetics of an imipenem-cilastatin combination].

Singlas E.

Presse Med. 1990 Apr 4;19(13):598-605. French.

PMID:
2139939
34.

Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation.

Taburet AM, Guibert J, Kitzis MD, Sorensen H, Acar JF, Singlas E.

J Antimicrob Chemother. 1990 Feb;25 Suppl B:23-31.

PMID:
2312443
35.

Do we need highly sensitive analytical techniques in phase I?

Singlas E.

Fundam Clin Pharmacol. 1990;4 Suppl 2:135s-140s. Review.

PMID:
2093624
36.

[Pharmacokinetics of zidovudine (AZT) and its metabolite (G-AZT) in healthy subjects and in patients with kidney failure].

Pioger JC, Taburet AM, Colin JN, Colaneri S, Fillastre JP, Singlas E.

Therapie. 1989 Nov-Dec;44(6):401-4. French.

PMID:
2623653
37.

[Effect of hepatic failure upon the pharmacokinetics of cefixime].

Singlas E, Lebrec D, Gaudin C, Montay G, Roche G, Taburet AM.

Presse Med. 1989 Oct 11;18(32):1587-8. French.

PMID:
2530538
38.

Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis.

Singlas E, Pioger JC, Taburet AM, Colin JN, Fillastre JP.

Clin Pharmacol Ther. 1989 Aug;46(2):190-7.

PMID:
2758728
39.

Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis.

Pioget JC, Wolff M, Singlas E, Laisne MJ, Clair B, Regnier B, Vachon F.

Antimicrob Agents Chemother. 1989 Jun;33(6):933-6.

40.

Pharmacokinetics of ornidazole in patients with acute viral hepatitis, alcoholic cirrhosis, and extrahepatic cholestasis.

Taburet AM, Attali P, Bourget P, Etienne JP, Singlas E.

Clin Pharmacol Ther. 1989 Apr;45(4):373-9.

PMID:
2702794
41.

Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients.

Singlas E, Pioger JC, Taburet AM, Colaneri S, Fillastre JP.

Eur J Clin Pharmacol. 1989;36(6):639-40. No abstract available.

PMID:
2776824
42.

Lack of interaction between nizatidine and warfarin during chronic administration.

Cournot A, Berlin I, Sallord JC, Singlas E.

J Clin Pharmacol. 1988 Dec;28(12):1120-2.

PMID:
2907521
43.

Pharmacokinetics of rilmenidine.

Singlas E, Ehrhardt JD, Zech P, Pozet N, Genissel P.

Am J Cardiol. 1988 Feb 24;61(7):54D-59D.

PMID:
2894159
44.

Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.

Sultan E, Richard C, Pezzano M, Auzepy P, Singlas E.

Eur J Clin Pharmacol. 1988;34(6):637-43.

PMID:
3169115
45.

[Pharmacokinetics of nifedipine in tablet form in the elderly].

Garnier-Moiroux A, Henry JF, Taburet AM, Forette F, Singlas E.

Therapie. 1987 Oct-Dec;42(6):511-4. French. No abstract available.

PMID:
3441894
46.

[Extraction of drugs by dialysis].

Singlas E, Lebelle AV.

Therapie. 1987 Oct-Dec;42(6):529-40. Review. French. No abstract available.

PMID:
3327192
47.

Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis.

Wolff M, Boutron L, Singlas E, Clair B, Decazes JM, Regnier B.

Antimicrob Agents Chemother. 1987 Jun;31(6):899-902.

48.

Pharmacokinetics of pefloxacin and amikacin administered simultaneously to patients undergoing resuscitation.

Sultan E, Singlas E, Richard C, Auzepy P.

Chemioterapia. 1987 Jun;6(2 Suppl):305-6. No abstract available.

PMID:
3509424
49.

Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.

Singlas E, Taburet AM, Landru I, Albin H, Ryckelinck JP.

Eur J Clin Pharmacol. 1987;31(5):589-93.

PMID:
3830244
50.

Pharmacokinetics of ornidazole in patients with severe liver cirrhosis.

Taburet AM, Delion F, Attali P, Thebault JJ, Singlas E.

Clin Pharmacol Ther. 1986 Sep;40(3):359-64.

PMID:
3742940

Supplemental Content

Loading ...
Support Center